These innovative treatments, Semaglutide , represent a significant advancement in treating metabolic dysfunction and conceivably associated disorders. They all are classified as GLP-1 hormone agonists , indicating they function to replicate the body's GLP-1 peptide, stimulating metabolic secretion and reducing hunger . Although Retatrutide each … Read More